Inhibition of protein kinase Cα prevents endothelial cell migration and vascular tube formation in vitro and myocardial neovascularization in vivo

Circulation Research

Volumn 90, Issue 5, 2002, Pages 609-616

  Wang, Aihong ^a   Nomura, Motohiro ^a   Patan, Sybill ^a   Ware, J Anthony ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Angiogenesis; Endothelial cells; Myocardial function; Protein kinase C

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOROTHIOIC ACID; PROTEIN KINASE C ALPHA; VASCULOTROPIN; VITRONECTIN;

ANGIOGENESIS; ARTICLE; ASSAY; CELL ADHESION; CELL GROWTH; CELL MIGRATION; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME INHIBITION; EXTRACELLULAR MATRIX; HEART INFARCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ANIMALS; CELL ADHESION; CELL DIVISION; CELL MOVEMENT; CELLS, CULTURED; CORONARY VESSELS; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION; HUMANS; ISOENZYMES; LIGATION; LYMPHOKINES; MALE; MAP KINASE KINASE KINASE 3; MAP KINASE KINASE KINASES; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; NEOVASCULARIZATION, PHYSIOLOGIC; OLIGONUCLEOTIDES, ANTISENSE; ORGAN SPECIFICITY; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN KINASE C-ALPHA; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; VITRONECTIN;

EID: 0037155777     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000012503.30315.E8     Document Type: Article

References (31)

1. Angiogenesis in ischemic heart disease
2. Gene therapy through signal transduction pathways and angiogenic growth factors as therapeutic targets in breast cancer
3. Hyperlipidemic endothelial injury and angiogenesis
4. Thrombin promotes endothelial cell alignment in Matrigel in vitro and angiogenesis in vivo
5. The potential for isoenzyme-selective modulation of protein kinase C
6. Identification of PKC-isoform-specific biological actions using pharmacologic approaches
7. Role of protein kinase C in attachment, spreading, and migration of human endothelial cells
8. Two distinct mechanisms mediate a differential regulation of protein kinase C isozymes in acute and prolonged myocardial ischemia
9. Kip1
10. Enhancement of migration by protein kinase Cα and inhibition of proliferation and cell cycle progression by protein kinase Cδ in capillary endothelial cells
11. Requirement for protein kinase C θ for cell cycle progression and formation of actin stress fibers and filopodia in vascular endothelial cells
12. Modified hippocampal long-term potentiation in PKCγ-mutant mice
13. Immunodeficiency in protein kinase Cβ-deficient mice
14. A novel nociceptor signaling pathway revealed in protein kinase CE mutant mice
15. κB activation in mature but not immature T lymphocytes
16. Down-regulation of protein kinase C δ activity enhances endothelial cell adaptation to hypoxia
17. 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells
18. 3 subunit for carcinoma cell spreading or migration on vitronectin and fibrinogen
19. Biological action of leptin as an angiogenic factor
20. Myocyte apoptosis during acute myocardial infarction in the mouse localizes to hypoxic regions but occurs independently of p53
21. PKC-E is required for mechano-sensitive activation of ERK1/2 in endothelial cells
22. The proliferative effect of vascular endothelial growth factor protein kinase C-α and protein kinase C-ζ
23. Requirement for protein kinase C activation in basic fibroblast growth factor-induced human endothelial cell proliferation
24. Definition of two angiogenic pathways by distinct α v integrins
25. Calcium antagonists ameliorate ischemia-induced endothelial cell permeability by inhibiting protein kinase C
26. Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides
27. Integrin-induced protein kinase Cα and Cε translocation to focal adhesions mediates vascular smooth muscle cell spreading
28. Intracellular disposition and metabolism of fluorescently-labeled unmodified and modified oligonu-cleotides microinjected into mammalian cells
29. Site specific enzymatic cleavage of RNA
30. Phase I study of an antisense oligonucleotide to protein kinase C-α (ISIS 3521/CGP64128A) in patients with cancer